| （単位：千ドル） | 3Q20 | 1Q21 | 2Q21 | 3Q21 | 1Q22 | 2Q22 | 3Q22 | 3Q23 | 2Q23 | 3Q23 | 1Q24 | 2Q24 | 3Q24 | 1Q25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 研究開発費 | 5,992 | 7,500 | 7,664 | 9,162 | 11,836 | 11,462 | 13,666 | 15,073 | 13,843 | 13,586 | 13,186 | 14,628 | 16,947 | 17,441 |
| 営業費用 | 8,701 | 11,674 | 13,050 | 15,097 | 18,619 | 17,885 | 19,375 | 21,480 | 20,122 | 19,628 | 18,221 | 20,170 | 21,888 | 21,564 |
| 営業利益 | -8,701 | -11,674 | -13,050 | -15,097 | -18,619 | -17,885 | -19,375 | -21,480 | -20,122 | -19,628 | -18,221 | -20,170 | -21,888 | -21,564 |
| 経常（税引前）利益 | -8,761 | -11,598 | -12,874 | -14,992 | -18,431 | -17,312 | -18,238 | -19,128 | -17,432 | -16,640 | -15,270 | -17,386 | -19,152 | -19,633 |
| 法人税等合計 | 3 | 4 | - | 19 | 2 | -2 | -9 | - | 4 | - | - | -16,173 | 74 | -2,197 |
| 実効税率（％） | - | - | - | - | ||||||||||
| 純利益 | -8,764 | -11,602 | -12,874 | -15,011 | -18,433 | -17,310 | -18,229 | -19,128 | -17,436 | -16,640 | -15,270 | -1,213 | -19,226 | -17,436 |
| 一株あたり利益 | - | - | - | - | - | - | -0.4 | -0.42 | -0.38 | -0.34 | -0.3 | -0.02 | -0.37 | -0.34 |
| 希薄化後一株あたり利益 | - | - | - | - | - | - | -0.4 | -0.42 | -0.38 | -0.34 | -0.3 | -0.02 | -0.37 | -0.34 |